Dolutegravir in Mexico for special populations: A cost analysis perspective
AIDS Rev. 2021 Jul 1. doi: 10.24875/AIDSRev.M21000042. Online ahead of print.ABSTRACTIntegrase strand-transfer inhibitors (INSTI) are the latest class of antiretrovirals registered in Mexico. They include raltegravir (RAL), elvitegravir/cobicistat (EVG/c), dolutegravir (DTG) and bictegravir (BIC). Along with international guidelines, Mexico adopted the use of INSTI about two years ago as initial antiretroviral therapy (ART). This is partially due to the increase in the pre-treatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI), mainly efavirenz (EFV). Furthermore, INSTI depict greater efficacy, saf...
Source: AIDS Reviews - July 1, 2021 Category: Infectious Diseases Authors: Banda Marco Herrera Cristina Reynaga Cristhian Rangel Sigfrido Josue Del Angel Angel Reyes Prudente Isidoro Source Type: research
Dolutegravir in Mexico for special populations: A cost analysis perspective
AIDS Rev. 2021 Jul 1. doi: 10.24875/AIDSRev.M21000042. Online ahead of print.ABSTRACTIntegrase strand-transfer inhibitors (INSTI) are the latest class of antiretrovirals registered in Mexico. They include raltegravir (RAL), elvitegravir/cobicistat (EVG/c), dolutegravir (DTG) and bictegravir (BIC). Along with international guidelines, Mexico adopted the use of INSTI about two years ago as initial antiretroviral therapy (ART). This is partially due to the increase in the pre-treatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI), mainly efavirenz (EFV). Furthermore, INSTI depict greater efficacy, saf...
Source: AIDS Reviews - July 1, 2021 Category: Infectious Diseases Authors: Banda Marco Herrera Cristina Reynaga Cristhian Rangel Sigfrido Josue Del Angel Angel Reyes Prudente Isidoro Source Type: research
Dolutegravir in Mexico for special populations: A cost analysis perspective
AIDS Rev. 2021 Jul 1. doi: 10.24875/AIDSRev.M21000042. Online ahead of print.ABSTRACTIntegrase strand-transfer inhibitors (INSTI) are the latest class of antiretrovirals registered in Mexico. They include raltegravir (RAL), elvitegravir/cobicistat (EVG/c), dolutegravir (DTG) and bictegravir (BIC). Along with international guidelines, Mexico adopted the use of INSTI about two years ago as initial antiretroviral therapy (ART). This is partially due to the increase in the pre-treatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI), mainly efavirenz (EFV). Furthermore, INSTI depict greater efficacy, saf...
Source: AIDS Reviews - July 1, 2021 Category: Infectious Diseases Authors: Banda Marco Herrera Cristina Reynaga Cristhian Rangel Sigfrido Josue Del Angel Angel Reyes Prudente Isidoro Source Type: research
Dolutegravir in Mexico for special populations: A cost analysis perspective
AIDS Rev. 2021 Jul 1. doi: 10.24875/AIDSRev.M21000042. Online ahead of print.ABSTRACTIntegrase strand-transfer inhibitors (INSTI) are the latest class of antiretrovirals registered in Mexico. They include raltegravir (RAL), elvitegravir/cobicistat (EVG/c), dolutegravir (DTG) and bictegravir (BIC). Along with international guidelines, Mexico adopted the use of INSTI about two years ago as initial antiretroviral therapy (ART). This is partially due to the increase in the pre-treatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI), mainly efavirenz (EFV). Furthermore, INSTI depict greater efficacy, saf...
Source: AIDS Reviews - July 1, 2021 Category: Infectious Diseases Authors: Banda Marco Herrera Cristina Reynaga Cristhian Rangel Sigfrido Josue Del Angel Angel Reyes Prudente Isidoro Source Type: research
Dolutegravir in Mexico for special populations: A cost analysis perspective
AIDS Rev. 2021 Jul 1. doi: 10.24875/AIDSRev.M21000042. Online ahead of print.ABSTRACTIntegrase strand-transfer inhibitors (INSTI) are the latest class of antiretrovirals registered in Mexico. They include raltegravir (RAL), elvitegravir/cobicistat (EVG/c), dolutegravir (DTG) and bictegravir (BIC). Along with international guidelines, Mexico adopted the use of INSTI about two years ago as initial antiretroviral therapy (ART). This is partially due to the increase in the pre-treatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI), mainly efavirenz (EFV). Furthermore, INSTI depict greater efficacy, saf...
Source: AIDS Reviews - July 1, 2021 Category: Infectious Diseases Authors: Banda Marco Herrera Cristina Reynaga Cristhian Rangel Sigfrido Josue Del Angel Angel Reyes Prudente Isidoro Source Type: research
